On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share of ﾣ20 million in government investment. The three projects include work on an effective vaccine, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale. Another project will examine how existing treatments could be repurposed to treat coronavirus.